Drug-maker Cipla has appointed Sameer Goel as its country-head for India, effective from today.
With experience of over 26 years, Goel comes from multinational drug major GlaxoSmithKline.
He will report to Cipla Managing Director and Global Chief Executive Subhanu Saxena. Saxena too, who assumed office early last year, came from multinational Novartis.
On Goel’s appointment, Saxena said, “This appointment signals the continuation of Cipla’s strategy of strengthening the highly experienced senior management team and to show our strong determination to increase the market share in India.”
In his last assignment, Goel led a $0.4-billion business, based out of Johannesburg, with responsibility for 44 markets in sub-Saharan Africa.
He was responsible for managing the finances in these markets with regional hubs and multiple manufacturing sites across South Africa, Nigeria and Kenya.
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.